
While not necessarily “new,” growth hormone releasing peptides could become an “issue,” said John Travis of NSF International.

While not necessarily “new,” growth hormone releasing peptides could become an “issue,” said John Travis of NSF International.

The alliance could eventually include a centralized software platform that enables QA managers to manage multiple certifications.

Pending food manufacturing regulations mean manufacturers and suppliers must work together toward compliance.

Experts in DNA testing have come together in a new white paper questioning proper use in the ongoing dietary supplement investigation led by NY AG Eric Schneiderman.

Qualitas Health discusses pursuing GRAS affirmation for food and beverage use.

What's changing? Industry initiative for enhanced self-regulation of GRAS practices is likely.

FDA’s Food Safety Modernization Act: 2014 actions and 2015 deadlines

Will industry’s messaging be heard in the fight against New York Attorney General Eric Schneiderman?

Key issues facing the natural products industry in 2015, according to Nutritional Outlook’s editorial advisory board.

Krill, menhaden, and salmon oils (both farmed and wild)-which previously were excluded-will now be included in the draft standard.

Will one randomized controlled trial (RCT) become the new standard for any company making disease-related claims?

The push for regulating the ingredient comes after two young men died from using powdered caffeine last year.

Will the latest proposed revisions for Prop 65 actually lead to fewer lawsuits and more informed consumers?

The Council for Responsible Nutrition weighs in on a new caffeine assessment in Europe.

The EU opinion includes details on caffeine's combo with alcohol and exercise, plus safe doses for children.

The NAD self-regulatory program for the dietary supplement industry will continue for at least another three years.

DASCA enables DEA to more quickly classify designer anabolic steroids as controlled substances and to go after companies spiking.

The guide advises companies on steps to prevent economically motivated adulteration (EMA) at the ingredient level.

Oryzatein is now considered GRAS when used to replace soy and whey protein, or when used in conjunction with soy and whey protein.

Companies can reference warning letters to learn what not to do, the association says.

Why the supplements industry should start with the military to convince policymakers to adopt broad-scale recommendations.

Navigating China’s complex natural-products industry is easier, thanks to the USCHPA.

The industrial-hemp champions are finally seeing decades of persistence start to pay off.

An approved flax/cholesterol health claim is just one of the council’s 2014 highlights.

A pioneer in the world of non-GMO testing, certification, and education-at home and abroad.

Baby food and pet food still dominate the DHA market.

How are regulatory concerns in a number of regions, most notably the EU, changing the marketing of digestive-health products?

Despite messiness in U.S. pet regulations, ingredient suppliers are still innovating ingredients for animal nutrition.

A lot of us, it turns out

Appearing with some frequency are consent orders requiring at least two well-designed randomized controlled clinical trials (RCT).